Moolec Science (MLECW) Change in Inventory (2022 - 2024)
Moolec Science (MLECW) posted Change in Inventory of $837998.0 for Q4 2024, down 19.37% sequentially from $1.0 million in Q3 2024, and up 415.01% YoY from $162716.1 in Q1 2024.
Moolec Science (MLECW) Change in Inventory (2022 - 2024) Analysis & Trends
Moolec Science has reported Change in Inventory for 3 years, with the latest figure at $837998.0 in Q4 2024.
- Quarterly Change in Inventory rose 415.01% year-over-year to $837998.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $17.4 million (up 280.72% YoY) and the FY2025 annual result came in at $34.9 million, up 128.19% from the prior year.
- Change in Inventory retreated to $837998.0 in Q4 2024 per MLECW's latest filing, from $1.0 million in the prior quarter.
- Over five years, Change in Inventory peaked at $15.2 million in Q2 2024 and troughed at -$9.4 million in Q2 2023.
- A 3-year average of $715807.0 and a median of $142407.5 in 2022 frame the typical range for Change in Inventory.
- The widest YoY moves for Change in Inventory: up 7582.99% in 2023, down 1847742.47% in 2023.
- Over 3 years, Change in Inventory stood at $215219.0 in 2022, then sank by 223.61% to -$266026.0 in 2023, then soared by 415.01% to $837998.0 in 2024.
- According to Business Quant data, Change in Inventory over the past three periods registered $837998.0, $1.0 million, and $15.2 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 837,998.00 |
| Dec 31, 2024 | 837,998.00 |
| Sep 30, 2024 | 1.04 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 15.24 Mn |
| Jun 30, 2024 | 15.24 Mn |
| Mar 31, 2024 | 245,501.00 |
| Mar 31, 2024 | 245,501.00 |
| Dec 31, 2023 | -266,026.00 |
| Dec 31, 2023 | -266,026.00 |
| Sep 30, 2023 | 69,596.00 |
| Sep 30, 2023 | 69,596.00 |
| Jun 30, 2023 | -9.44 Mn |
| Jun 30, 2023 | -9.44 Mn |
| Mar 31, 2023 | 33,000.00 |
| Mar 31, 2023 | 33,000.00 |
| Dec 31, 2022 | 215,219.00 |
| Dec 31, 2022 | 215,219.00 |
| Sep 30, 2022 | 621,727.00 |
| Sep 30, 2022 | 621,727.00 |